FGFBP1 and asthma: To conclude, we illustrated that hyperactivation of the mTORC1-STAT3-FGFBP1 pathway in the airway epithelium contributes to the progress of angiogenesis (Fig. 8G), suggesting that this pathway should be specifically targeted for the treatment of asthma.